P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma

By Ong Christy C.   Jubb Adrian M.   Jakubiak Diana   Zhou Wei   Rudolph Joachim   Haverty Peter M.   Kowanetz Marcin   Yan Yibing   Tremayne Jarrod   Lisle Richard   Harris Adrian L.   Friedman Lori S.   Belvin Marcia   Middleton Mark R.   Blackwood Elizabeth M.   Koeppen Hartmut   Hoeflich Klaus P.  

Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. : 606-607

Oxford University Press

Access to resources Recommend Favorite

Overexpression of p21-activated kinase 1 promotes endometrial cancer progression

By                

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1547-1555

Spandidos Publications

Access to resources Recommend Favorite

Mitogen-activated protein kinase kinase 3 induces cell cycle arrest via p38 activation mediated Bmi-1 downregulation in hepatocellular carcinoma

By Wang Lin   Chen Chen   Feng Shuzhi   Lei Ping   Tian Jianli  

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 243-248

Spandidos Publications

Access to resources Recommend Favorite

P21-activated protein kinase 1 is overexpressed in gastric cancer and induces cancer metastasis

By Li Liang-Hui   Luo Qi   Zheng Min-Hua   Pan Chao   Wu Guo-Yang   Lu Yi-Zhuo   Feng Bo   Chen Xue-Hua   Liu Bing-Ya  

Oncology Reports, Vol. 27, Iss. 5, 2012-05 ,pp. : 1435-1442

Spandidos Publications

Access to resources Recommend Favorite

Additive effects of EGF and IL-1β regulate tumor cell migration and invasion in gastric adenocarcinoma via activation of ERK1/2

By                          

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 291-301

Spandidos Publications

Access to resources Recommend Favorite